The Association Among Serum Growth Differentiation Factor 15 Level and Suicidal Ideation is Dependent on Testosterone Deficiency in Depressive Patients

References

• Vöhringer PA, Perlis RH. Discriminating between bipolar disorder and major depressive disorder. Psychiatr Clin North Am. 2016;39(1):1–10. doi:10.1016/j.psc.2015.10.001
   PubMed Web of Science ®Google Scholar
• Cuijpers P, Beekman AT, Reynolds CF III. Preventing depression: a global priority. JAMA. 2012;307:1033–1034.
   PubMed Web of Science ®Google Scholar
• Croarkin PE, Nakonezny PA, Deng ZD, et al. High-frequency repetitive TMS for suicidal ideation in adolescents with depression. J Affect Disord. 2018;239:282–290.
   PubMed Web of Science ®Google Scholar
• Rukundo GZ, Kemigisha E, Ocan M, Adriko W, Akena DH. A systematic review of the risk factors for suicidal ideation, suicidal attempt and completed suicide among children and adolescents in sub-Saharan Africa between 1986 and 2018: protocol for a systematic review of observational studies. Syst Rev. 2018;7(1):230–238.
   PubMedGoogle Scholar
• Blier P. Neurotransmitter targeting in the treatment of depression. J Clin Psychiatry. 2013;74:19–24.
   PubMed Web of Science ®Google Scholar
• Malekzadeh A, de Groot V, Beckerman H, van Oosten BW, Blankenstein MA, Teunissen CE. Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases. Methods. 2012;56(4):508–513.
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446–457.
   PubMed Web of Science ®Google Scholar
• Skowrońska M, Skrzyńska M, Machowski M, et al. Plasma growth differentiation factor 15 levels for predicting serious adverse events and bleeding in acute pulmonary embolism: a prospective observational study. Pol Arch Intern Med. 2020;130(9):757–765.
   PubMedGoogle Scholar
• Altendahl M, Maillard P, Harvey D, et al. An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury. PLoS One. 2020;15(1):e0227835.
   PubMed Web of Science ®Google Scholar
• Yin J, Zhu Z, Guo D, et al. Increased growth differentiation factor 15 is associated with unfavorable clinical outcomes of acute ischemic stroke. Clin Chem. 2019;65(4):569–578.
   PubMed Web of Science ®Google Scholar
• Kim DH, Lee D, Lim H, et al. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer’s disease. Biochem Biophys Res Commun. 2018;504(4):933–940.
   PubMed Web of Science ®Google Scholar
• Lu X, Duan J, Cheng Q, Lu J. The association between serum growth differentiation factor-15 and 3-month depression after acute ischemic stroke. J Affect Disord. 2020;260:695–702.
   PubMed Web of Science ®Google Scholar
• Barch DM, Shirtcliff EA, Elsayed NM, et al. Testosterone and hippocampal trajectories mediate relationship of poverty to emotion dysregulation and depression. Proc Natl Acad Sci U S A. 2020;117(36):22015–22023.
   PubMed Web of Science ®Google Scholar
• Giltay EJ, van der Mast RC, Lauwen E, Heijboer AC, Mwm DW, Comijs HC. Plasma testosterone and the course of major depressive disorder in older men and women. Am J Geriatr Psychiatry. 2017;25(4):425–437.
   PubMed Web of Science ®Google Scholar
• Kakehi Y, Segawa T, Wu XX, Kulkarni P, Dhir R, Getzenberg RH. Downregulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia. Prostate. 2004;59:351–356.
   PubMed Web of Science ®Google Scholar
• Liu T, Bauskin AR, Zaunders J, Brown DA, Pankhurst S, Russell PJ. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res. 2003;63:5034–5040.
   PubMed Web of Science ®Google Scholar
• Zitzmann M. Testosterone, mood, behaviour and quality of life. Andrology. 2020;8(6):1598–1605.
   PubMed Web of Science ®Google Scholar
• Tichomirowa MA, Keck ME, Schneider HJ, et al. Endocrine disturbances in depression. J Endocrinol Invest. 2005;28(1):89–99.
   PubMed Web of Science ®Google Scholar
• McHenry J, Carrier N, Hull E, Kabbaj M. Sex differences in anxiety and depression: role of testosterone. Front Neuroendocrinol. 2014;35(1):42–57.
   PubMed Web of Science ®Google Scholar
• Walther A, Breidenstein J, Miller R. Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis. JAMA Psychiatry. 2019;76(1):31–40.
   PubMed Web of Science ®Google Scholar
• Jayaraman A, Lent-Schochet D, Pike CJ. Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function. J Neuroinflammation. 2014;11:162–169.
   PubMed Web of Science ®Google Scholar
• Machado V, Haas SJ. von Bohlen Und Halbach O, Wree A, Krieglstein K, Unsicker K, Spittau B. Growth/Differentiation Factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson’s Disease. Neurobiol Dis. 2016;88:1–15.
   PubMed Web of Science ®Google Scholar
• Nicholas MN, Gooderham M. Psoriasis, depression, and suicidality. Skin Therapy Lett. 2017;22(3):1–4.
   PubMedGoogle Scholar
• Frye MA, Nassan M, Jenkins GD, et al. Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders. Transl Psychiatry. 2015;5(12):e689.
   PubMedGoogle Scholar
• Wollert KC, Kempf T, Wallentin L. Growth Differentiation Factor 15 as a biomarker in cardiovascular disease. Clin Chem. 2017;63(1):140–151.
   PubMed Web of Science ®Google Scholar
• Worthmann H, Kempf T, Widera C, et al. Growth differentiation factor 15 plasma levels and outcome after ischemic stroke. Cerebrovasc Dis. 2011;32(1):72–78.
   PubMed Web of Science ®Google Scholar
• Liu JY, Dong XX, Lu JN, et al. . Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis. FEBS Open Bio. 2018;9(1):35–42.
   PubMed Web of Science ®Google Scholar
• Liu H, Dai W, Cui Y, Lyu Y, Li Y. Potential associations of circulating growth differentiation factor-15 with sex hormones in male patients with coronary artery disease. Biomed Pharmacother. 2019;114:108–122.
   Web of Science ®Google Scholar
• Liu H, Lyu Y, Li D, et al. Potential relation between soluble growth differentiation factor-15 and testosterone deficiency in male patients with coronary artery disease. Cardiovasc Diabetol. 2019;18(1):21–36.
   PubMedGoogle Scholar
• Chen J, Dai W, Zhu C, Liu H, Li Y, Zhang P. Circulating levels of growth differentiation factor 15 and sex hormones in male patients with HBV-associated hepatocellular carcinoma. Biomed Pharmacother. 2020;121:109–117.
   Web of Science ®Google Scholar
• Brites D, Fernandes A. Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation. Front Cell Neurosci. 2015;9:476–483.
   PubMed Web of Science ®Google Scholar
• Voet S, Prinz M, van Loo G. Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol Med. 2019;25(2):112–123.
   PubMed Web of Science ®Google Scholar
• Collongues N, Patte-Mensah C, De Seze J, Mensah-Nyagan AG, Derfuss T. Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics. Expert Rev Neurother. 2018;18(6):515–522.
   PubMed Web of Science ®Google Scholar
• Slavich GM, Sacher J. Stress, sex hormones, inflammation, and major depressive disorder: extending social signal transduction theory of depression to account for sex differences in mood disorders. Psychopharmacology (Berl). 2019;236(10):3063–3079.
   PubMed Web of Science ®Google Scholar